Dosing for Allergic Asthma
XOLAIR is administered every 2 or 4 weeks. The patient's age, pretreatment serum total immunoglobulin E (IgE) level (IU/mL), and body weight (lb or kg) are used to determine doses (mg) and dosing frequency. Periodically reassess the need for continued therapy based on the patient’s disease severity and level of asthma control. 1
Dosing for CIU
XOLAIR is administered every 4 weeks. Dosing of XOLAIR in CIU patients is flat-fixed and NOT dependent on serum IgE (free or total) level or body weight. The appropriate duration of therapy has not been evaluated. Periodically reassess the need for continued therapy. 1
XOLAIR CO-PAY PROGRAM
Help eligible patients with out-of-pocket costs for XOLAIR and administration through the XOLAIR Co-pay Program.
Download and share support resources, such as the Patient Treatment Guides, with your Allergic Asthma and CIU patients when discussing XOLAIR.